STOCK TITAN

Clarus: Kanders gains borrowing capacity on 1.68M shares

The pledge amendments provide Warren B. Kanders previously unavailable margin borrowing capacity on 1,679,147 Clarus shares serving as collateral for a Loan Agreement.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Clarus Corp (CLAR) is the issuer named in an amended ownership disclosure in which Warren B. Kanders may be deemed to beneficially own 8,124,220 shares as of September 28, 2026, approximately 20.2%. The amount includes 1,905,997 options exercisable or exercisable within 60 days. Kanders GMP Holdings, LLC separately reports 1,528,465 shares, included in—not additional to—Kanders’ total. The percentage calculation uses 38,288,155 shares outstanding as of July 30, 2026, plus Kanders’ option shares.

Warren B. Kanders received previously unavailable margin borrowing capacity on 1,679,147 shares serving as collateral for a Loan Agreement with Bank of America, N.A. The collateral comprises 500,000 shares beneficially owned by Holdings and 1,179,147 beneficially owned by Kanders.

Kanders beneficial ownership 8,124,220 shares As of September 28, 2026
Kanders ownership percentage approximately 20.2% Based on shares outstanding as of July 30, 2026, plus option shares
Holdings beneficial ownership 1,528,465 shares Included in, and not additional to, Kanders’ reported shares
Holdings ownership percentage approximately 4.0% Based on shares outstanding as of July 30, 2026
Collateral shares 1,679,147 shares Shares serving as collateral for a Loan Agreement
Shares outstanding 38,288,155 shares As of July 30, 2026
Options included in Kanders’ beneficial ownership 1,905,997 shares Exercisable or exercisable within 60 days of September 28, 2026
beneficially own financial
"may be deemed to beneficially own 8,124,220 shares"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
margin borrowing capacity financial
"previously unavailable margin borrowing capacity"
Pledge Agreements financial
"amending their respective Pledge Agreements"
exercisable within 60 days financial
"options to purchase 1,905,997 shares exercisable within 60 days"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CLAR shares does Warren B. Kanders beneficially own?

Warren B. Kanders may be deemed to beneficially own 8,124,220 shares, approximately 20.2%, as of September 28, 2026. The calculation uses 38,288,155 shares outstanding as of July 30, 2026, plus 1,905,997 option shares.

What changed under the CLAR pledge amendments?

Warren B. Kanders received previously unavailable margin borrowing capacity on 1,679,147 shares serving as collateral for a Loan Agreement with Bank of America, N.A. The collateral comprises 500,000 shares beneficially owned by Kanders GMP Holdings, LLC and 1,179,147 beneficially owned by Kanders.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





18270P109

(CUSIP Number)
Robert L. Lawrence
Michael Best & Friedrich LLP, 600 3rd Avenue, 35th Floor
New York, NY, 10016
(212) 541-6222

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
09/28/2026

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
Footnote to Rows 7 and 9: Includes 4,444,326 shares held directly by Mr. Kanders; 1,528,465 shares held by Kanders GMP Holdings, LLC ("Holdings"), of which Mr. Kanders is a majority member and a trustee of the manager; options to purchase an aggregate of 1,905,997 shares of Common Stock which were previously granted under the Company's Amended and Restated 2015 Stock Incentive Plan and that are presently exercisable or exercisable within 60 days of September 28, 2026 ; 1,935 shares held as UTMA custodian; 125,221 shares held by his spouse in a UTA Trust Account of which he is sole trustee; and 17,832 shares held as joint tenants with rights of survivorship. The amount reported above as beneficially owned by Mr. Kanders excludes (i) a restricted stock award of 500,000 shares of Common Stock granted to him on March 4, 2022 under the Company's 2015 Stock Incentive Plan, all of which will vest if, on or before March 4, 2032, the Fair Market Value (as defined in that plan) of the Common Stock equals or exceeds $50.00 per share for 20 consecutive trading days; and (ii) a restricted stock award of 500,000 shares of Common Stock granted to him on March 14, 2023 under that plan, of which (A) 250,000 shares will vest if, on or before March 14, 2033, the Fair Market Value of the Common Stock equals or exceeds $15.00 per share for 20 consecutive trading days and (B) 250,000 shares will vest if, on or before March 14, 2033, the Fair Market Value of the Common Stock equals or exceeds $18.00 per share for 20 consecutive trading days. Footnote to Rows 8 and 10: Consists of 100,444 shares beneficially owned by Mr. Kanders' spouse, as to which Mr. Kanders reports shared voting and dispositive power. Footnote to Row 11: The aggregate includes the shares in Rows 7 and 8, without duplication. Footnote to Row 13: The percentage of shares of common stock reported as being beneficially owned by Mr. Kanders is based upon 38,288,155 shares outstanding as of July 30, 2026, as reported in the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2026 filed with the Securities and Exchange Commission on August 6, 2026, plus 1,905,997 shares underlying the options included in Mr. Kanders' beneficial ownership, for a denominator of 40,194,152 shares.


SCHEDULE 13D




Comment for Type of Reporting Person:
Footnote to Rows 8, 10 and 11: Holdings reports shared voting and dispositive power over 1,528,465 shares of Common Stock. Mr. Kanders is a majority member and a trustee of the manager of Holdings and may be deemed to beneficially own those shares. These shares are included in, and are not additional to, the shares reported by Mr. Kanders. Footnote to Row 13: The percentage of shares of common stock reported as being beneficially owned is based upon 38,288,155 shares outstanding as of July 30, 2026, as reported in the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2026 filed with the Securities and Exchange Commission on August 6, 2026. Mr. Kanders' options that are presently exercisable or exercisable within 60 days of September 28, 2026 are not included in Holdings' denominator.


SCHEDULE 13D


Warren B. Kanders
Signature:/s/ Warren B. Kanders
Name/Title:Warren B. Kanders
Date:10/01/2026
Kanders GMP Holdings, LLC
Signature:/s/ Warren B. Kanders
Name/Title:Warren B. Kanders / Managing Member
Date:10/01/2026

Keep reading